PTM-FLEX
Synthetic biology approach for the design of new-to-nature peptide-based antibiotic molecules
| Coordinatore | EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH
Organization address
address: Raemistrasse 101 contact info |
| Nazionalità Coordinatore | Switzerland [CH] |
| Totale costo | 199˙317 € |
| EC contributo | 199˙317 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2013-IEF |
| Funding Scheme | MC-IEF |
| Anno di inizio | 2014 |
| Periodo (anno-mese-giorno) | 2014-04-15 - 2016-04-14 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH
Organization address
address: Raemistrasse 101 contact info |
CH (ZUERICH) | coordinator | 199˙317.60 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The rise of pathogenic bacteria that are resistant against a variety of antibiotic treatment emphasizes the need for novel active molecules. One promising novel class of active molecules is genetically encoded and ribosomally synthesized peptides, as they offer the potential to employ directed evolution approaches across a huge sequence space directly on an active substance in order to engineer novel activities and thus introduce a novel engineering principle into antibiotic development. However, in many cases the activity of the peptide molecule depends on substantial posttranslational modifications (PTMs) which give the peptides conformational stability and protect against proteolytic degradation. Consequently, the degrees of freedom in the engineering of such peptides on sequence level are highly dependent on the flexibility of the PTM-machinery to accept such changes. Here, we propose a synthetic biology approach to study systematically the flexibility of PTM-machineries for the class of lanthipepetides in order to assemble a highly flexible machinery that will support a broad range of engineering measures and thus optimize the chances to discover molecules with modified or completely novel activities. We also propose to implement a high-throughput screen for the bioactivity of these molecules in order to be able to engineer specific enzymes of the PTM-machinery for increased flexibility and to finally implement large scale directed evolution screens for novel antibiotic activities.'